Bruker Corporation (BRKR): Price and Financial Metrics

Bruker Corporation (BRKR): $81.65

0.87 (+1.08%)

POWR Rating

Component Grades














  • BRKR scores best on the Growth dimension, with a Growth rank ahead of 99.32% of US stocks.
  • The strongest trend for BRKR is in Growth, which has been heading up over the past 31 weeks.
  • BRKR ranks lowest in Momentum; there it ranks in the 34th percentile.

BRKR Stock Summary

  • With a one year PEG ratio of 400.01, Bruker Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 91.14% of US stocks.
  • With a price/earnings ratio of 60.51, Bruker Corp P/E ratio is greater than that of about 84.73% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for BRKR is currently 31.24, higher than 83.96% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to Bruker Corp, a group of peers worth examining would be JHX, ULTA, JBHT, OTEX, and MHK.
  • Visit BRKR's SEC page to see the company's official filings. To visit the company's web site, go to

BRKR Valuation Summary

  • In comparison to the median Healthcare stock, BRKR's EV/EBIT ratio is 61.05% higher, now standing at 43.
  • Over the past 243 months, BRKR's price/sales ratio has gone down 4.7.
  • BRKR's price/sales ratio has moved down 4.7 over the prior 243 months.

Below are key valuation metrics over time for BRKR.

Stock Date P/S P/B P/E EV/EBIT
BRKR 2020-01-16 4.1 9.8 40.2 31.9
BRKR 2018-10-16 2.8 6.5 55.2 24.7
BRKR 2010-12-21 2.3 5.7 25.8 16.1
BRKR 2009-02-27 0.7 2.3 13.1 11.0
BRKR 2008-12-04 0.7 2.4 13.3 11.2
BRKR 2007-12-14 2.4 5.1 44.4 29.2

BRKR Growth Metrics

  • Its 2 year net income to common stockholders growth rate is now at 110.6%.
  • Its year over year cash and equivalents growth rate is now at -12.41%.
  • Its 4 year cash and equivalents growth rate is now at 278.99%.
BRKR's revenue has moved up $276,700,000 over the prior 34 months.

The table below shows BRKR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 2,118.2 395.2 204
2020-12-31 1,987.5 332.2 157.8
2020-09-30 1,959.9 265.4 157.5
2020-06-30 1,969.6 235.4 164.5
2020-03-31 2,035.2 234.2 176.9
2019-12-31 2,072.6 213.4 197.2

BRKR Price Target

For more insight on analysts targets of BRKR, see our BRKR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $75.00 Average Broker Recommendation 1.68 (Moderate Buy)

BRKR Stock Price Chart Interactive Chart >

Price chart for BRKR

BRKR Price/Volume Stats

Current price $81.65 52-week high $84.41
Prev. close $80.78 52-week low $37.27
Day low $78.36 Volume 901,200
Day high $82.01 Avg. volume 591,868
50-day MA $75.97 Dividend yield 0.19%
200-day MA $62.81 Market Cap 12.37B

Bruker Corporation (BRKR) Company Bio

Bruker Corporation designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. The company was founded in 1991 and is based in Billerica, Massachusetts.

BRKR Latest News Stream

Event/Time News Detail
Loading, please wait...

BRKR Latest Social Stream

Loading social stream, please wait...

View Full BRKR Social Stream

Latest BRKR News From Around the Web

Below are the latest news stories about Bruker Corp that investors may wish to consider to help them evaluate BRKR as an investment opportunity.

Bruker (BRKR) Q2 Earnings and Revenues Top Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 10.00% and 6.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 2, 2021

Bruker Reports Second Quarter 2021 Financial Results

BILLERICA, Mass., August 02, 2021--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2021.

Yahoo | August 2, 2021

Bruker (BRKR) Hits Fresh High: Is There Still Room to Run?

Bruker (BRKR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Yahoo | August 2, 2021

Rapid Microbiology Testing Market worth $6.7 billion by 2026 - Leading Key Players are bioMérieux SA (France), Bruker Corporation (US), Danaher Corporation (US)

According to the new market research report "Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System, PCR, Mass Spectrometry), Method (Growth, Nucleic Acid, Viability), Applications (Clinical Diagnosis, Pharma, Environmental) - Global Forecast to 2026", published by MarketsandMarkets, the

OpenPR | July 30, 2021

FLEX Q1 Earnings and Revenues Surpass Estimates, Up Y/Y

Flex (FLEX) Q1 results reflect continued strength in the Agility Solutions and Reliability Solutions segments.

Yahoo | July 30, 2021

Read More 'BRKR' Stories Here

BRKR Price Returns

1-mo 4.55%
3-mo 17.84%
6-mo 46.60%
1-year 85.28%
3-year 132.63%
5-year 276.74%
YTD 51.03%
2020 6.58%
2019 71.85%
2018 -12.82%
2017 62.96%
2016 -12.16%

BRKR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BRKR Dividend History

Continue Researching BRKR

Want to see what other sources are saying about Bruker Corp's financials and stock price? Try the links below:

Bruker Corp (BRKR) Stock Price | Nasdaq
Bruker Corp (BRKR) Stock Quote, History and News - Yahoo Finance
Bruker Corp (BRKR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8931 seconds.